Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Robust Overall Survival and Sustained Efficacy Outcomes during Long Term Exposure to Momelotinib in JAK Inhibitor Naïve and Previously JAK Inhibitor Treated Intermediate/High Risk Myelofibrosis Patients

Srdan Verstovsek, MD PhD, Miklos Egyed, MD PhD, Ewa Lech-Marańda, MD PhD, Tomasz Sacha, MDPhD, Viviane Dubruille, MD, Stephen T. Oh, MD, Doroteya Todorieva-Todorova, MD, Francesco Passamonti, MD, Blanca Xicoy, MD, Björn Andréasson, MD PhD, Daniel El Fassi, MD, Claire Harrison, DM, FRCP, FRCPath, Donal P. McLornan, MRCP, PhD FRCPath, Mary Frances Frances McMullin, MDFRCPath,FRCP, Christof Scheid, MD, MArianne Tang Severinsen, MD PhD, Mark M Kowalski, MD PhD, Gregg Smith, PhD, Ruben Mesa, MD

Blood (2020) 136 (Supplement 1): 51–52.

https://doi.org/10.1182/blood-2020-135872

Published: 2020

Journal Articles

Fertility Rates in Young Hodgkin Lymphoma Survivors: A Danish Nationwide Cohort Study of 769 Patients

Andreas Kiesbye Øvlisen, MD, Lasse H. Jakobsen, PhD, Kristian Hay Kragholm, Martin Hutchings, MD PhD, Henrik Frederiksen, MD PhD Prof, Peter Kamper, Sandra Eloranta, Caroline Weibull, Ingrid Glimelius, MD PhD, Karin Ekstrom Ekstroem Smedby, Marianne Tang Severinsen, MD PhD, Tarec Christoffer C. El-Galaly, MD

Blood (2019) 134 (Supplement_1): 2841.

https://doi.org/10.1182/blood-2019-122642

Published: 2019

Journal Articles

Genomic Profiling of a Phase III Clinical Trial of Interferon Versus Hydroxyurea in MPN Patients Reveals Mutation-Specific and Treatment-Specific Patterns of Response

Blood (2019) 134 (Supplement_1): 4202.

https://doi.org/10.1182/blood-2019-126164

Published: 2019

Journal Articles

Longer Distance to a Specialized Treatment Center Does Not Adversely Affect Access to Treatment or Outcome in Acute Myeloid Leukemia: A National Population-Based Cohort Study

Michael Buch Tostesen, MD, Jan M. Norgaard, MD PhD, Mette Nørgaard, MD PhD, Bruno C. Medeiros, MD, Claus Werenberg Marcher, MD PhD, Ulrik Malthe Overgaard, MD, Claudia Schöllkopf, MD PhD, Marianne Tang Severinsen, MD PhD, Lene Sofie Granfeldt Oestgaard, MDPhD

Blood (2018) 132 (Supplement 1): 613.

https://doi.org/10.1182/blood-2018-99-110922

Published: 2018

Journal Articles

From Mild Cytopenia to Overt MDS and AML, the Mutational Profile Predicts Progression, but Not Survival

Jakob Werner Hansen, MD, Morten Munk Johansen, MD, Maj Karoline Westman, MSc, Leonie Saft, MD PhD, Lene Dissing Sjö, MD PhD, Claus Werenberg Marcher, MD PhD, Mette Skov Holm, MD PhD, Marios Dimitriou, PhD, Mohsen Karimi, PhD, Klas Raaschou-Jensen, MD, Andreas Birkedal Glenthøj, MD PhD, Marianne Tang Severinsen, MD PhD, Eva Hellström-Lindberg, MD PhD, Mette Klarskov Andersen, MD DMSc, Kirsten Grønbæk, Professor, MD DMSc

Blood (2018) 132 (Supplement 1): 794.

https://doi.org/10.1182/blood-2018-99-110767

Published: 2018

Journal Articles

The Risk of Venous Thromboembolism Is High in Chronic Lymphocytic Leukemia Because of Additional Cancers: A Danish National Cohort Study

Inger Lise Gade, Signe Juul Riddersholm, MD PhD, Ilse Christiansen, Christian Torp-Pedersen, MD Professor, Søren Risom Kristensen, MD Professor, Marianne Tang Severinsen, MD PhD

Blood (2018) 132 (Supplement 1): 364.

https://doi.org/10.1182/blood-2018-99-110242

Published: 2018

Journal Articles

Long-Term Efficacy and Safety of Recombinant Interferon Alpha-2 Vs. Hydroxyurea in Polycythemia Vera: Preliminary Results from the Three-Year Analysis of the Daliah Trial - a Randomized Controlled Phase III Clinical Trial

Blood (2018) 132 (Supplement 1): 580.

https://doi.org/10.1182/blood-2018-99-111255

Published: 2018

Journal Articles

Autoimmune Diseases, Infections, Use of Antibiotics and the Risk of Acute Myeloid Leukemia: A National Population-Based Case-Control Study

Lene Sofie Granfeldt Østgård, MD PhD, Mette Nørgaard, MD PhD, Lars Pedersen, MSc, PhD, René Østgård, MD PhD, Ulrik Malthe Overgaard, MD, Claudia Schöllkopf, MD PhD, Marianne Tang Severinsen, MD PhD, Claus Werenberg Marcher, MD PhD, Morten Krogh Jensen, MD Dr.MDSci

Blood (2017) 130 (Supplement 1): 1304.

https://doi.org/10.1182/blood.V130.Suppl_1.1304.1304

Published: 2017

Journal Articles

Does NSAID Consumption Reduce the Risk of Acute Myeloid Leukemia? a National Population-Based Case-Control Study

Lene Sofie Granfeldt Østgård, MD PhD, Mette Nørgaard, MD PhD, Lars Pedersen, MSc, PhD, René Østgård, MD PhD, Marianne Tang Severinsen, MD PhD, Claudia Schöllkopf, MD PhD, Claus Werenberg Marcher, MD PhD, Lone Smidstrup Friis, MD PhD, Morten Krogh Jensen, MD Dr.Sc.

Blood (2017) 130 (Supplement 1): 1305.

https://doi.org/10.1182/blood.V130.Suppl_1.1305.1305

Published: 2017

Journal Articles

Promyelocytic Leukemia Patients Surviving the Critical Initial Phase Have Survival Equivalent to That of the Calendar Year-, Sex-, and Age-Matched General Population

Jorne Lionel Biccler, MSc, Marianne Tang Severinsen, MD PhD, Lene Sofie Granfeldt Oestgaard, MD PhD, Claus Werenberg Marcher, MD PhD, Peter Møller, MD, Claudia Schöllkopf, MD PhD, Lone Smidstrup Friis, MD PhD, Lasse Hjort Jakobsen, MSc, Tarec Christoffer El-Galaly, MD PhD, Jan M. Nørgaard, MD PhD

Blood (2017) 130 (Supplement 1): 2595.

https://doi.org/10.1182/blood.V130.Suppl_1.2595.2595

Published: 2017

Journal Articles

Acute Myeloid Leukemia Classification System That Associates Normal Myeloid-Cell Subset Gene Signatures with Prognosis

Anna Amanda Schönherz, PhD, Julie Støve Bødker, PhD, Alexander Schmitz, Rasmus Froberg Brøndum, Senior Bioinformatician, Lasse Hjort Jakobsen, MSc, Marianne Tang Severinsen, MD PhD, Tarec Christoffer El-Galaly, MD PhD, Karen Dybkær, Professor, Martin Bøgsted, Professor, Hans Erik Johnsen, MD Professor

Blood (2017) 130 (Supplement 1): 2689.

https://doi.org/10.1182/blood.V130.Suppl_1.2689.2689

Published: 2017

NARROW

Robust Overall Survival and Sustained Efficacy Outcomes during Long Term Exposure to Momelotinib in JAK Inhibitor Naïve and Previously JAK Inhibitor Treated Intermediate/High Risk Myelofibrosis Patients

Fertility Rates in Young Hodgkin Lymphoma Survivors: A Danish Nationwide Cohort Study of 769 Patients

Genomic Profiling of a Phase III Clinical Trial of Interferon Versus Hydroxyurea in MPN Patients Reveals Mutation-Specific and Treatment-Specific Patterns of Response

Longer Distance to a Specialized Treatment Center Does Not Adversely Affect Access to Treatment or Outcome in Acute Myeloid Leukemia: A National Population-Based Cohort Study

From Mild Cytopenia to Overt MDS and AML, the Mutational Profile Predicts Progression, but Not Survival

The Risk of Venous Thromboembolism Is High in Chronic Lymphocytic Leukemia Because of Additional Cancers: A Danish National Cohort Study

Long-Term Efficacy and Safety of Recombinant Interferon Alpha-2 Vs. Hydroxyurea in Polycythemia Vera: Preliminary Results from the Three-Year Analysis of the Daliah Trial - a Randomized Controlled Phase III Clinical Trial

Autoimmune Diseases, Infections, Use of Antibiotics and the Risk of Acute Myeloid Leukemia: A National Population-Based Case-Control Study

Does NSAID Consumption Reduce the Risk of Acute Myeloid Leukemia? a National Population-Based Case-Control Study

Promyelocytic Leukemia Patients Surviving the Critical Initial Phase Have Survival Equivalent to That of the Calendar Year-, Sex-, and Age-Matched General Population

Acute Myeloid Leukemia Classification System That Associates Normal Myeloid-Cell Subset Gene Signatures with Prognosis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only